|
|
 |
| |
BioCrystal has patents, allowed patent applications, pending U.S. patent applications, and pending foreign counterparts, that are all broadly directed to the various platform technologies under development: |
| |
Cancer
|
Immunomodulating therapies for the treatment of cancer |
| |
|
|
| |
Cancer |
|
| |
Issued Patents: 8 |
| |
6,224,866 |
Immunotherapy of B Cell Involvement in Progression of Solid,
Nonlymphoid Tumors |
| |
|
|
| |
6,245,752 |
Compositions and Methods for Tolerization in Immune Complex-Mediated Disease Progression |
| |
|
|
| |
6,251,616 |
Methods and Assay Kits for Detecting Altered Mononuclear Cell
Phenotype Related to a Pro-Tumor Immune Response |
| |
|
|
| |
6,268,350 |
Polynucleotides for Inhibiting Metastasis and Tumor Cell Growth |
| |
|
|
| |
6,365,124 |
Compositions for Detecting and Surgically Removing Lymphoid Tissue
Involved in Tumor Progression |
| |
|
|
| |
6,418,338 |
Method for Detecting and Surgically Removing Lymphoid Tissue
Involved in Tumor Progression |
| |
|
|
| |
6,760,612 |
Method for Detecting and Surgically Removing Lymphoid Tissue Involved in Tumor Progression
|
| |
|
|
| |
6,762,032 |
Compositions, Assay Kits and Methods for use Related to a Disease Condition Comprising Multiple Sclerosis and/or a Pro-MS Immune Response
|
| |
|
|
| |
Trademarks/Service Marks |
| |
|
|
| |
BIOCRYSTAL |
| |
|
|
| |
2,375,917 |
BioCrystal Service Mark Registration U.S. PTO |
| |
|
|
 |
|
|
|
| |
| |
 |
|
